Research has demonstrated that ZNF683+CD8+T cell totality is important for anti-tumor immunity, with high levels of this ZNF683 gene marker detected in peripheral blood samples from patients with renal cell carcinoma, melanoma, and lung cancer (32). Here, ZNF683 is linked to neoplasm.